
Bioorganic and Medicinal Chemistry Letters p. 1421 - 1426 (1996)
Update date:2022-08-04
Topics:
Kawanishi, Yasuyuki
Ishihara, Shoichi
Tsushima, Tadahiko
Seno, Kaoru
Miyagoshi, Masanori
Hagishita, Sanji
Ishikawa, Michio
Shima, Noriko
Shimamura, Mayumi
Ishihara, Yasunobu
The joint type of hybrid molecules composed of two pharmacophore moieties taken from histamine H2 and gastrin receptor antagonists have been designed and synthesized to exhibit dual histamine H2 and gastrin receptor antagonistic activities. Here we report the importance of spacers as well as binding sites of both pharmacophores for the dual activity.
View MoreSuzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Changyi Xinxing Technology Development Co., Ltd.
Contact:0086-510-86651065(Time Zone:8),86651656
Address:94 Yingbinxilu WestRoad, Huangtu Town, Jiangyin City, Jiangsu, China
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Doi:10.1007/s11164-012-0751-2
(2013)Doi:10.1021/jm300396n
(2012)Doi:10.1002/cmdc.201200225
(2012)Doi:10.1016/S0040-4039(00)76155-7
(1968)Doi:10.1007/s00044-012-0074-2
(2013)Doi:10.1134/S107032840912001X
(2009)